Diagnostic and medical testing refers to a specific type of testing, usually used in detecting disease and to monitor its progression. Additionally, diagnostic tools & equipment are also used in guiding the treatment and assessing its effectiveness. Diagnostic testing is mainly two types: invasive diagnostic testing and non-invasive diagnostic testing. Invasive diagnostic tests include piercing the skin or entering the body for instance taking a blood sample, colonoscopies and biopsies. Additionally, non-invasive testing involves the exploit of advanced diagnostic equipment that creates images/pictures of organs, bones and soft tissues inside the body without having to make an incision.
Some of the commonly used image-guided diagnostic testing procedures include Magnetic Resonance Imaging (MRI), radiography or X-rays, mammography, ultrasound and others. MRI generally uses a strong magnet & radio waves to produce the highly detailed images of the inside the body. X-ray or radiography uses radio-waves to create the images of bones & organs. Mammography is often used as a screening & diagnostic tool for women to detect the abnormal growths in the breast. Additionally, ultrasound uses sound-waves, computer and transducer to create the images of internal organs.
Referring to the study, “UAE Diagnostic and Medical Testing Market Current Analysis and Forecast (2017-2026)” some of the key companies that are presently operating in the UAE diagnostic & medical testing market include Al Borg lab, NRL (National Reference Laboratories), Medsol, Purehealth, Unilabs, MENA Labs, Cleveland Clinic Abu Dhabi, Thumbay Labs, SRL Diagnostics UAE, Life Diagnostics & York Lab and among others. In order to reinforce their position in the diagnostic & medical testing market, leading players are now focusing on executing different strategies including recent developments, mergers & acquisitions, joint ventures, product innovations, collaborations and partnerships.
In terms of testing type, UAE diagnostic & medical testing market can be segregated as specialized testing and routine testing. Routine testing segment holds major share in regional market due to rise in prevalence of chronic diseases such as heart diseases, cancer and asthma. In terms of testing model, market can be segregated as outsources and in-house. In-house testing model segment is anticipated to exhibit substantial growth rate as it is less expensive, convenient and confidential during the forecast period. In terms of type of players, market can be segregated as private clinics, public institutions, private hospitals and independent laboratories. Private clinics and private hospitals are likely to witness higher CAGR caused by growth in healthcare expenditure coupled with increase in healthcare awareness among people during the forecast period. In addition, in terms of end-user, UAE diagnostic & medical testing market can be segregated as COVID, B2C end-users, B2B end-users and lab management.
Rise in number of In vitro diagnostic (IVD) test, followed by growth in healthcare infrastructure and better financial models, increase in lifestyle diseases, adequate reimbursement policies and growth in patient population are some major factors, which are responsible for growth of the UAE diagnostic & medical testing market. Apart from this, high cost of diagnostic & medical tests may impact the market.
Based on country-wise analysis, the UAE diagnostic & medical testing market can be bifurcated as Dubai, Abu-Dhabi and rest of UAE. Abu-Dhabi country dominates the regional market because of increase in number of laboratories across the region. Dubai country is expected to witness higher growth rate due to increase in government focus & favorable policies on healthcare over the forecast period. It is projected that future of the UAE diagnostic & medical testing market will be bright on account of growth in spending in health infrastructure during the forecast period.
For More Information, refer to below link:-
Ankur Gupta, Head Marketing & Communications